About

Fred J.W. Chung is an associate in the Intellectual Property Group in the firm's Silicon Valley office.

Latest Post

In Allergan USA, Inc. v. MSN Laboratories Private Ltd., No. 2024-1061 (Fed. Cir. August 13, 2024), the Federal Circuit reversed the District Court of Delaware’s invalidity determination of certain claims of U.S. Patent No. 7,741,356 (“the ’356 patent”) for obviousness-type double patenting. The Federal Circuit also reversed the district court’s invalidity determination of certain claims of U.S. Patent Nos. 11,007,179 (“the ’179 patent”), 11,090,291 (“the ’291 patent”), 11,160,792 (“the ’792 patent”), and 11,311,516 (“the ’516 patent”) for lack of written description.

Continue Reading Federal Circuit Emphasizes Role of Filing Dates, Reversing Obviousness-Type Double Patenting Invalidation

About

Fred J.W. Chung is an associate in the Intellectual Property Group in the firm's Silicon Valley office.

Subscribe: Subscribe via RSS